Literature DB >> 33687947

Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis.

Lindsay A Broadfield1,2, João André Gonçalves Duarte1,2, Roberta Schmieder1,2, Dorien Broekaert1,2, Koen Veys3, Mélanie Planque1,2, Kim Vriens1,2, Yasuaki Karasawa4,5,6, Francesco Napolitano7, Suguru Fujita4, Masashi Fujii8, Miki Eto4, Bryan Holvoet9, Roman Vangoitsenhoven10, Juan Fernandez-Garcia1,2, Joke Van Elsen1,2, Jonas Dehairs11, Jia Zeng12, James Dooley13, Rebeca Alba Rubio14, Jos van Pelt15, Thomas G P Grünewald14,16,17,18, Adrian Liston13, Chantal Mathieu10, Christophe M Deroose9, Johannes V Swinnen11, Diether Lambrechts19, Diego di Bernardo7,20, Shinya Kuroda4, Katrien De Bock21, Sarah-Maria Fendt22,2.   

Abstract

Hepatic fat accumulation is associated with diabetes and hepatocellular carcinoma (HCC). Here, we characterize the metabolic response that high-fat availability elicits in livers before disease development. After a short term on a high-fat diet (HFD), otherwise healthy mice showed elevated hepatic glucose uptake and increased glucose contribution to serine and pyruvate carboxylase activity compared with control diet (CD) mice. This glucose phenotype occurred independently from transcriptional or proteomic programming, which identifies increased peroxisomal and lipid metabolism pathways. HFD-fed mice exhibited increased lactate production when challenged with glucose. Consistently, administration of an oral glucose bolus to healthy individuals revealed a correlation between waist circumference and lactate secretion in a human cohort. In vitro, palmitate exposure stimulated production of reactive oxygen species and subsequent glucose uptake and lactate secretion in hepatocytes and liver cancer cells. Furthermore, HFD enhanced the formation of HCC compared with CD in mice exposed to a hepatic carcinogen. Regardless of the dietary background, all murine tumors showed similar alterations in glucose metabolism to those identified in fat exposed nontransformed mouse livers, however, particular lipid species were elevated in HFD tumor and nontumor-bearing HFD liver tissue. These findings suggest that fat can induce glucose-mediated metabolic changes in nontransformed liver cells similar to those found in HCC. SIGNIFICANCE: With obesity-induced hepatocellular carcinoma on a rising trend, this study shows in normal, nontransformed livers that fat induces glucose metabolism similar to an oncogenic transformation. ©2021 American Association for Cancer Research.

Entities:  

Year:  2021        PMID: 33687947     DOI: 10.1158/0008-5472.CAN-20-1954

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Tumour fatty acid metabolism in the context of therapy resistance and obesity.

Authors:  Andrew J Hoy; Shilpa R Nagarajan; Lisa M Butler
Journal:  Nat Rev Cancer       Date:  2021-08-20       Impact factor: 60.716

2.  Exercise-Induced Browning of White Adipose Tissue and Improving Skeletal Muscle Insulin Sensitivity in Obese/Non-obese Growing Mice: Do Not Neglect Exosomal miR-27a.

Authors:  Dongxue Wang; Xihuan Zhang; Yibai Li; Lihong Jia; Lingling Zhai; Wei Wei; Li Zhang; Hongkun Jiang; Yinglong Bai
Journal:  Front Nutr       Date:  2022-06-17

3.  Gut Microbiome Differences in Rescued Common Kestrels (Falco tinnunculus) Before and After Captivity.

Authors:  Kangqing Zhang; Xinxiang Wang; Xiang Gong; Jinling Sui
Journal:  Front Microbiol       Date:  2022-06-20       Impact factor: 6.064

4.  A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma.

Authors:  Da Mao; Meihong Xu; Qiyu Jiang; Huiwei Sun; Fang Sun; Ruichuang Yang; Yantao Chai; Xiaojuan Li; Boan Li; Yong Li
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

Review 5.  Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options.

Authors:  Chunye Zhang; Shuai Liu; Ming Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-23       Impact factor: 5.555

Review 6.  Cancer metabolism and dietary interventions.

Authors:  Lin Qian; Fan Zhang; Miao Yin; Qunying Lei
Journal:  Cancer Biol Med       Date:  2021-12-22       Impact factor: 4.248

7.  Sortilin 1 Promotes Hepatocellular Carcinoma Cell Proliferation and Migration by Regulating Immune Cell Infiltration.

Authors:  Yan Gao; Yan Li; Ziyan Song; Zhenxing Jin; Xiao Li; Chunluan Yuan
Journal:  J Oncol       Date:  2022-07-08       Impact factor: 4.501

Review 8.  Black phosphorous nanomaterials as a new paradigm for postoperative tumor treatment regimens.

Authors:  Yanhua Hou; Yang Fei; Zehong Liu; Yingqi Liu; Menghuan Li; Zhong Luo
Journal:  J Nanobiotechnology       Date:  2022-08-11       Impact factor: 9.429

9.  A Novel Metabolism-Related Gene Signature for Predicting the Prognosis of HBV-Infected Hepatocellular Carcinoma.

Authors:  Zhenfu Gao; Jingyun Chen; Yebin Zhou; Pan Deng; Lu Sun; Jun Qi; Ping Zhang
Journal:  J Oncol       Date:  2022-08-28       Impact factor: 4.501

Review 10.  Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges.

Authors:  Manoja K Brahma; Eduardo H Gilglioni; Lang Zhou; Eric Trépo; Pengyu Chen; Esteban N Gurzov
Journal:  Oncogene       Date:  2021-07-21       Impact factor: 8.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.